https://www.selleckchem.com/products/dbet6.html
Last, we leveraged the modularity of our platform to achieve enhanced therapeutic efficacy in a poorly immunogenic syngeneic mouse model through effective combinations with a probiotically produced cytokine, granulocyte-macrophage colony-stimulating factor (GM-CSF). Together, these results demonstrate that our engineered probiotic system bridges synthetic biology and immunology to improve upon checkpoint blockade delivery. Copyright © 2020 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Sc
Like
Comment
Share
